Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Special patients, special treatments

C Harris Spiridonidis¹

¹Hematology Oncology Consultants, Inc., Columbus, OH, USA.

Clinical Lung Cancer

|November 5, 2003

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2007

Same author

Phase I study of Doxil and vinorelbine in patients with advanced malignancies.

Cancer investigation·2004

Same author

Evaluating the effectiveness of epoetin alfa in community oncology practices.

Hematology (Amsterdam, Netherlands)·2003

Same author

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003

Same author

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003

Same author

Overlooking patient outcomes in a meta-analysis of trials of granulocyte colony-stimulating factor.

The American journal of medicine·2003